A comparison of lispro and regular insulin for the management of type 1 and type 2 diabetes in pregnancy
The DOI matches its Crossref record; 17 of the 18 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To describe perinatal outcomes of women with pregestational diabetes treated with short-acting, regular insulin and the short-acting insulin analogue, lispro. STUDY DESIGN: This was a prospective observational study of women with pregestational diabetes maintained on short-acting insulin regimens over a 3-year period. Clinical characteristics, aspects of diabetic therapy, and perinatal/neonatal outcomes were collected. RESULTS: Of 107 women, 49 were maintained on regular insulin and 58 utilized the insulin analogue, lispro. Frequency of type 1 diabetes, maternal age, overweight/obese pregravid body mass index (> or =25 kg/m2), preexisting hypertension, and presence of vascular disease were similar between groups. Women treated with lispro had a longer duration of diabetes (11.4 vs. 8.3 years, p = 0.04). Glycemic control was improved in women managed with lispro compared to regular insulin (HgbA1c 5.9 vs. 6.7, p = 0.009). Total insulin requirements were lower in the lispro group in the first (0.58 vs. 0.79 units/kg, p = 0.02), second (0.75 vs. 1.10 units/kg, p = 0.002), and third (0.98 vs. 1.25 units/kg, p = 0.03) trimesters of pregnancy. Mean infant birth weight was greater in the lispro group, whereas the rate of large for gestational age infants and ponderal indices were similar between groups. Malformation rate, gestational age at delivery, neonatal intensive care unit admission, neonatal length of stay, rates of respiratory distress syndrome, and hypoglycemia were similar. CONCLUSIONS: Women treated with lispro demonstrated improved glycemic control and lower total insulin requirements during pregnancy compared to those receiving regular insulin. Perinatal outcomes were similar between women treated with both types of insulin.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, both are associated with similar rates of prematurity, cesarean delivery, worsening of retinopathy, hypertensive complications, rates of shoulder dystocia, admission to a neonatal intensive care unit, and neonatal hypoglycemia.”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [158]
In the citing paper
“Rapid-acting insulin does not increase the risk of teratogenicity (30, 157, 158, 163–165).”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [158]
In the citing paper
“Compared with human regular (soluble) insulin, rapid-acting insulin used during pregnancy allows greater lifestyle flexibility, greater patient satisfaction, and improved quality of life (156) and may also provide better postprandial blood glucose control (157) and HbA1C reduction (158).”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [158]
In the citing paper
“In most other respects, rapid-acting insulin and regular insulin are comparable during pregnancy (30, 158–162).”
From Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline (2013) · cites this paper as [158]
In the citing paper
“In addition, the rapid-acting insulin analogs aspart and lispro have acceptable safety and efficacy profiles in pregnancy.59,60”
From Gestational Diabetes Mellitus (2019) · cites this paper as [60]
Citations
Cites
Prevention of Congenital Malformations in Infants of Insulin-dependent Diabetic Mothers
Fuhrmann, K., Reiher, H., Semmler, K., Fischer, F., Fischer, M., & Glöckner, E. (1983) · Diabetes Care · doi:10.2337/diacare.6.3.219 · Cited by 440
Maternal postprandial glucose levels and infant birth weight: the diabetes in early pregnancy study
Jovanovic-Peterson, L., Peterson, C. M., Reed, G. F., Metzger, B. E., Mills, J. L., Knopp, R. H., & Aarons, J. H. (1991) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(91)90637-7 · Cited by 411
Preconception Care of Diabetes: Glycemic Control Prevents Congenital Anomalies
Kitzmiller, J. L. (1991) · JAMA · doi:10.1001/jama.1991.03460060063025 · Cited by 397
Langer, O., Levy, J., Brustman, L., Anyaegbunam, A., Merkatz, R., & Divon, M. (1989) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(89)90371-2 · Cited by 376
The outcome of diabetic pregnancies in relation to the mother's blood sugar level
Karlsson, K., & Kjellmer, I. (1972) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(72)90118-4 · Cited by 355
Maternal postprandial glucose levels and infant birth weight: The Diabetes in Early Pregnancy Study
Jovanovic‐Peterson, L., Peterson, C., Reed, G., Metzger, B., Mills, J., Knopp, R., & Aarons, J. (1991) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(91)90499-u · Cited by 322
Anderson, J. H., Brunelle, R. L., Koivisto, V. A., Pfützner, A., Trautmann, M. E., Vignati, L., & DiMarchi, R. (1997) · Diabetes · doi:10.2337/diab.46.2.265 · Cited by 319
Pettitt, D. J., Knowler, W. C., Baird, H. R., & Bennett, P. H. (1980) · Diabetes Care · doi:10.2337/diacare.3.3.458 · Cited by 278
Metabolic and immunologic effects of insulin lispro in gestational diabetes.
Jovanovic, L., Ilic, S., Pettitt, D. J., Hugo, K., Gutierrez, M., Bowsher, R. R., & Bastyr, E. J. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1422 · Cited by 238
Langer, O., & Mazze, R. (1988) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(88)90578-9 · Cited by 158
Research works printed but not linked: 1
- Cypryk K, 2004, Med Sci Monit, 10, 29
Cited by
Hod, M., Kapur, A., Sacks, D. A., Hadar, E., Agarwal, M., Di Renzo, G. C., Roura, L. C., McIntyre, H. D., Morris, J. L., & Divakar, H. (2015) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(15)30033-3 · Cited by 767
Diabetes and Pregnancy: An Endocrine Society Clinical Practice Guideline
Blumer, I., Hadar, E., Hadden, D. R., Jovanovič, L., Mestman, J. H., Murad, M. H., & Yogev, Y. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2465 · Cited by 561
Thompson, D., Berger, H., Feig, D., Gagnon, R., Kader, T., Keely, E., Kozak, S., Ryan, E., Sermer, M., & Vinokuroff, C. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.044 · Cited by 377
Szmuilowicz, E. D., Josefson, J. L., & Metzger, B. E. (2019) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2019.05.001 · Cited by 364
Feig, D. S., Berger, H., Donovan, L., Godbout, A., Kader, T., Keely, E., & Sanghera, R. (2018) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2017.10.038 · Cited by 344
Metadata
- Authors
- Durnwald, C. P., & Landon, M. B.
- Affiliations
- The Ohio State University (US)
- Corresponding author
- Durnwald, Celeste P.
- ORCID
- Durnwald, Celeste P.
- Venue
- The Journal of Maternal-Fetal & Neonatal Medicine
- Publisher
- Informa UK Limited
- Published
- 2008-01
- Volume
- 21
- Issue
- 5
- Pages
- 309-313
- ISSN
- 1476-4954 (ISSN-L)
- 1476-7058
- OpenAlex
- W2008468334
- Cited by
- 61
- References
- 18
- Citations by year
- 2026: 1 · 2021: 4 · 2019: 6 · 2018: 4 · 2017: 5 · 2016: 4 · 2015: 5 · 2014: 4 · 2013: 8 · 2012: 5
- FWCI
- 5.35
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Maternal-Fetal & Neonatal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Gestational Diabetes Research and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- insulin lispro, regular insulin, insulin analogues, pregestational diabetes, type 1 diabetes, type 2 diabetes, diabetes in pregnancy, glycemic control, insulin requirement, perinatal outcomes, birth weight, large for gestational age, neonatal outcomes
- MeSH terms
- Adult, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Female, Humans, Hypoglycemic Agents, Infant, Newborn, Insulin, Pregnancy, Pregnancy in Diabetics, Pregnancy Outcome, Prospective Studies, Treatment Outcome, Insulin Lispro
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A comparison of lispro and regular insulin for the management of type 1 and type 2 diabetes in pregnancy. https://app.cochat.ai/papers/10.1080/14767050802022797
- The paper
- Durnwald, C. P., & Landon, M. B. (2008). A comparison of lispro and regular insulin for the management of type 1 and type 2 diabetes in pregnancy. The Journal of Maternal-Fetal & Neonatal Medicine. https://doi.org/10.1080/14767050802022797
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.